38708 Federal Register / Vol. 82, No. 156 / Tuesday, August 15, 2017 / Notices 

1The record is defined in sec. 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2 Vice Chairman David S. Johanson dissenting. 

contract personnel, solely for 

cybersecurity purposes. All contract 

personnel will sign appropriate 

nondisclosure agreements. 

Authority: These investigations are being 

conducted under authority of title VII of the 

Tariff Act of 1930; this notice is published 

pursuant to section 207.12 of the 

Commission’s rules. 

By order of the Commission. 

Issued: August 9, 2017. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2017–17177 Filed 8–14–17; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–1330 (Final)] 

Dioctyl Terephthalate (DOTP) From 

Korea; Determination 

On the basis of the record 1 developed 

in the subject investigation, the United 

States International Trade Commission 

(‘‘Commission’’) determines, pursuant 

to the Tariff Act of 1930 (‘‘the Act’’), 

that an industry in the United States is 

materially injured by reason of imports 

of dioctyl terephthalate (‘‘DOTP’’) from 

Korea, provided for in subheading 

2917.39.20 of the Harmonized Tariff 

Schedule of the United States, that have 

been found by the Department of 

Commerce (‘‘Commerce’’) to be sold in 

the United States at less than fair value 

(‘‘LTFV’’).2

Background 

The Commission, pursuant to section 

735(b) of the Act (19 U.S.C. 1673d(b)), 

instituted this investigation effective 

June 30, 2016, following receipt of a 

petition filed with the Commission and 

Commerce by Eastman Chemical 

Company, Kingsport, Tennessee. The 

Commission scheduled the final phase 

of the investigation following 

notification of a preliminary 

determination by Commerce that 

imports of DOTP from Korea were being 

sold at LTFV within the meaning of 

section 733(b) of the Act (19 U.S.C. 

1673b(b)). Notice of the scheduling of 

the final phase of the Commission’s 

investigation and of a public hearing to 

be held in connection therewith was 

given by posting copies of the notice in 

the Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register of April 

12, 2017 (82 FR 17691). The hearing was 

held in Washington, DC, on June 13, 

2017, and all persons who requested the 

opportunity were permitted to appear in 

person or by counsel. 

The Commission made this 

determination pursuant to section 

735(b) of the Act (19 U.S.C. 1673d(b)). 

It completed and filed its determination 

in this investigation on August 9, 2017. 

The views of the Commission are 

contained in USITC Publication 4713 

(August 2017), entitled Dioctyl 

Terephthalate (DOTP) from Korea: 

Investigation No. 731–TA–1330 (Final). 

By order of the Commission. 

Issued: August 9, 2017. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2017–17178 Filed 8–14–17; 8:45 am] 

BILLING CODE 7020–02–P 

JUDICIAL CONFERENCE OF THE 

UNITED STATES 

Meeting of the Judicial Conference 

Advisory; Committee on Rules of 

Criminal Procedure 

AGENCY: Judicial Conference of the 

United States, Advisory Committee on 

Rules of Criminal Procedure. 

ACTION: Notice of open meeting. 

SUMMARY: The Advisory Committee on 

Rules of Criminal Procedure will hold a 

meeting on October 24, 2017. The 

meeting will be open to public 

observation but not participation. An 

agenda and supporting materials will be 

posted at least 7 days in advance of the 

meeting at: http://www.uscourts.gov/ 

rules-policies/records-and-archivesrules-committees/agenda-books. 

DATES: October 24, 2017. 

TIME: 9:00 a.m. to 5:00 p.m. 

ADDRESSES: United States District Court 

for Illinois, Everett McKinley Dirksen 

United States Courthouse, 219 South 

Dearborn Street, Chicago, IL 60604. 

FOR FURTHER INFORMATION CONTACT: 

Rebecca A. Womeldorf, Rules 

Committee Secretary, Rules Committee 

Support Office, Administrative Office of 

the United States Courts, Washington, 

DC 20544, telephone (202) 502–1820. 

Dated: August 8, 2017. 

Rebecca A. Womeldorf, 

Rules Committee Secretary. 

[FR Doc. 2017–17147 Filed 8–14–17; 8:45 am] 

BILLING CODE 2210–55–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Medical Technology 

Enterprise Consortium 

Notice is hereby given that, on June 

23, 2017, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Medical Technology 

Enterprise Consortium (‘‘MTEC’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Appili Theraputics, Inc., 

Halifax, Nova Scotia, CANADA; 

BioTime, Inc., Alameda, CA; Chenega 

Healthcare Services, LLC, San Antonio, 

TX; Critical Innovations LLC, Venice, 

CA; Embody LLC, Norfolk, VA; Kansas 

State University, Manhattan, KS; 

NovaHep AB, Gothenburg, SWEDEN; 

Pulmotect, Inc., Houston, TX; QBiotics 

Limited, Taringa, Queensland, 

AUSTRALIA; SIMETRI, Inc., Winter 

Park, FL; SpherIngenics, Inc., 

Richmond, VA; Spherium Biomed SL, 

Barcelona, SPAIN; Techulon, Inc., 

Blacksburg, VA; The Trustees of 

Columbia University in the City of New 

York, New York, NY; The University of 

Texas Health Science Center at Houston, 

Houston, TX; UT Health San Antonio, 

San Antonio, TX; and Vapogenix, Inc., 

Houston, TX, have been added as 

parties to this venture. 

Also, MedPro Technologies, Inc., San 

Antonio, TX; MetArmor, Inc., Glen 

Gardner, NJ; Michigan Technological 

University, Houghton, MI; and 

Organovo, Inc., San Diego, CA, have 

withdrawn as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and MTEC 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On May 9, 2014, MTEC filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 9, 2014 (79 FR 32999). 

The last notification was filed with 

the Department on April 19, 2017. A 

notice was published in the Federal 

mstockstill on DSK30JT082PROD with NOTICES